CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	2 Months Ended	1 Months Ended	3 Months Ended
	Mar. 31, 2015	Jan. 31, 2015	Mar. 31, 2014
Cash flows from operating activities
Net income	$ 16,420
Adjustments to reconcile net income to net cash provided by operating activities:
Realized investment losses (gains)	40,004
Amortization of deferred policy acquisition costs and value of business acquired	28,036
Capitalization of deferred policy acquisition costs	(49,851)
Depreciation and amortization expense	8,268
Deferred income tax	(14,345)
Accrued income tax	110,290
Interest credited to universal life and investment products	130,209
Policy fees assessed on universal life and investment products	(188,403)
Change in reinsurance receivables	29,955
Change in accrued investment income and other receivables	(41,574)
Change in policy liabilities and other policyholders' funds of traditional life and health products	(114,029)
Trading securities:
Maturities and principal reductions of investments	27,556
Sale of investments	31,584
Cost of investments acquired	(75,342)
Other net change in trading securities	51,908
Amortization of premiums and accretion of discounts on investments	57,807
Change in other liabilities	(41,118)
Other, net	95,891
Net cash provided by operating activities	103,266
Cash flows from investing activities
Maturities and principal reductions of investments, available-for-sale	45,532
Sale of investments, available-for-sale	721,935
Cost of investments acquired, available-for-sale	(1,185,394)
Change in investments, held-to-maturity	(20,000)
Mortgage loans:
New lendings	(248,508)
Repayments	223,644
Change in investment real estate, net	21
Change in policy loans, net	16,502
Change in other long-term investments, net	(34,184)
Change in short-term investments, net	15,799
Net unsettled security transactions	5,100
Purchase of property and equipment	(709)
Net cash (used in) provided by investing activities	(460,262)
Cash flows from financing activities
Issuance (repayment) of non-recourse funding obligations	20,000
Repurchase program borrowings	460,123
Dividends/Return of capital to parent company	(145,000)
Investment product deposits and change in universal life deposits	462,674
Investment product withdrawals	(471,218)
Other financing activities, net	139
Net cash provided by (used in) financing activities	326,718
Change in cash	(30,278)
Cash at beginning of period	378,903
Cash at end of period	348,625
Predecessor
Cash flows from operating activities
Net income		88,522	102,549
Adjustments to reconcile net income to net cash provided by operating activities:
Realized investment losses (gains)		(102,703)	(30,981)
Amortization of deferred policy acquisition costs and value of business acquired		4,817	65,882
Capitalization of deferred policy acquisition costs		(22,799)	(59,764)
Depreciation and amortization expense		796	1,792
Deferred income tax		91,709	(9,161)
Accrued income tax		(48,469)	50,082
Interest credited to universal life and investment products		79,088	210,800
Policy fees assessed on universal life and investment products		(90,288)	(253,394)
Change in reinsurance receivables		(98,148)	(14,104)
Change in accrued investment income and other receivables		(1,285)	(24,820)
Change in policy liabilities and other policyholders' funds of traditional life and health products		176,119	15,963
Trading securities:
Maturities and principal reductions of investments		17,946	25,257
Sale of investments		26,422	47,457
Cost of investments acquired		(27,289)	(37,070)
Other net change in trading securities		(26,901)	(20,589)
Amortization of premiums and accretion of discounts on investments		3,420	10,018
Change in other liabilities		211,031	10,203
Other, net		(133,928)	(71,952)
Net cash provided by operating activities		148,060	18,168
Cash flows from investing activities
Maturities and principal reductions of investments, available-for-sale		59,028	221,379
Sale of investments, available-for-sale		200,716	374,956
Cost of investments acquired, available-for-sale		(150,030)	(900,627)
Change in investments, held-to-maturity			(20,000)
Mortgage loans:
New lendings		(100,530)	(126,896)
Repayments		45,741	222,646
Change in investment real estate, net		7	49
Change in policy loans, net		6,365	22,634
Change in other long-term investments, net		(25,372)	(72,988)
Change in short-term investments, net		(39,312)	(41,467)
Net unsettled security transactions		37,510	45,145
Purchase of property and equipment		(648)	(3,072)
Net cash (used in) provided by investing activities		33,475	(278,241)
Cash flows from financing activities
Issuance (repayment) of non-recourse funding obligations			19,989
Repurchase program borrowings			125,000
Dividends/Return of capital to parent company			(75,000)
Investment product deposits and change in universal life deposits		169,233	696,229
Investment product withdrawals		(240,147)	(577,210)
Other financing activities, net		(4)
Net cash provided by (used in) financing activities		(70,918)	189,008
Change in cash		110,617	(71,065)
Cash at beginning of period		268,286	345,579
Cash at end of period		$ 378,903	$ 274,514